Free Trial

Leidos (LDOS) Financials

Leidos logo
$124.73 +0.38 (+0.31%)
Closing price 03:59 PM Eastern
Extended Trading
$125.68 +0.95 (+0.76%)
As of 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Leidos

Annual Income Statements for Leidos

This table shows Leidos' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/30/2015 12/30/2016 12/29/2017 12/28/2018 1/3/2020 1/1/2021 12/31/2021 12/30/2022 12/29/2023 1/3/2025 1/2/2026
Net Income / (Loss) Attributable to Common Shareholders
-323 244 366 581 667 628 753 685 199 1,254 1,448
Consolidated Net Income / (Loss)
-323 246 364 582 670 629 759 693 208 1,251 1,462
Net Income / (Loss) Continuing Operations
-330 246 364 582 670 629 759 693 208 1,251 1,462
Total Pre-Tax Income
-283 318 393 610 866 781 967 886 403 1,639 1,909
Total Operating Income
-214 407 559 731 912 984 1,152 1,088 621 1,827 2,109
Total Gross Profit
666 937 1,432 1,504 1,548 1,737 2,014 2,084 2,244 2,798 3,099
Total Revenue
5,063 7,043 10,170 10,194 11,094 12,297 13,737 14,396 15,438 16,662 17,174
Operating Revenue
5,063 7,043 10,170 10,194 11,094 12,297 13,737 14,396 15,438 16,662 17,174
Total Cost of Revenue
4,397 6,106 8,738 8,690 9,546 10,560 11,723 12,312 13,194 13,864 14,075
Operating Cost of Revenue
4,392 6,103 8,738 8,690 9,546 10,560 11,723 12,312 13,194 13,864 14,075
Total Operating Expenses
880 530 873 773 636 753 858 1,008 1,653 960 985
Selling, General & Admin Expense
310 422 737 729 689 770 851 951 942 983 999
Other Operating Expenses / (Income)
- - -3.00 0.00 -58 -68 -20 - - -39 -32
Impairment Charge
567 4.00 0.00 7.00 0.00 12 - 40 687 0.00 0.00
Restructuring Charge
3.00 104 139 37 5.00 39 27 17 24 16 18
Total Other Income / (Expense), net
-69 -89 -166 -121 -46 -203 -185 -190 -188 -188 -200
Interest & Investment Income
1.00 10 - 18 - 14 - -187 -182 -193 -203
Other Income / (Expense), net
5.00 -13 -26 -1.00 87 -38 -1.00 -3.00 -6.00 5.00 3.00
Income Tax Expense
47 72 29 28 196 152 208 193 195 388 447
Net Income / (Loss) Attributable to Noncontrolling Interest
0.00 2.00 -2.00 1.00 3.00 1.00 6.00 8.00 9.00 -3.00 14
Basic Earnings per Share
($4.36) $2.39 $2.41 $3.85 $4.66 $4.42 $5.34 $5.00 $1.45 $9.36 $11.31
Weighted Average Basic Shares Outstanding
74.13M 102M 151.46M 146.16M 141.40M 141.89M 140.51M 136.94M 135.78M 131.17M 126.39M
Diluted Earnings per Share
($4.36) $2.35 $2.38 $3.80 $4.60 $4.36 $5.27 $4.96 $1.44 $9.22 $11.14
Weighted Average Diluted Shares Outstanding
74.13M 102M 151.46M 146.16M 141.40M 141.89M 140.51M 136.94M 135.78M 131.17M 126.39M
Weighted Average Basic & Diluted Shares Outstanding
74.13M 102M 151.46M 146.16M 141.40M 141.89M 140.51M 136.94M 135.78M 131.17M 126.39M
Cash Dividends to Common per Share
$1.28 $1.28 $1.28 $1.28 $1.32 $1.36 $1.40 $1.44 $1.46 $1.54 $1.63

Quarterly Income Statements for Leidos

This table shows Leidos' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/29/2023 12/29/2023 3/29/2024 6/28/2024 9/27/2024 1/3/2025 4/4/2025 7/4/2025 10/3/2025 1/2/2026 4/3/2026
Net Income / (Loss) Attributable to Common Shareholders
-399 229 284 322 364 284 363 391 367 327 328
Consolidated Net Income / (Loss)
-396 230 283 324 362 282 365 393 369 335 335
Net Income / (Loss) Continuing Operations
-396 230 283 324 362 282 365 393 369 335 335
Total Pre-Tax Income
-388 310 368 426 470 375 478 518 484 429 429
Total Operating Income
-336 361 415 475 516 421 530 571 535 473 508
Total Gross Profit
587 595 638 705 762 693 757 782 821 739 761
Total Revenue
3,921 3,980 3,975 4,132 4,190 4,365 4,245 4,253 4,469 4,207 4,400
Operating Revenue
3,921 3,980 3,975 4,132 4,190 4,365 4,245 4,253 4,469 4,207 4,400
Total Cost of Revenue
3,334 3,385 3,337 3,427 3,428 3,672 3,488 3,471 3,648 3,468 3,639
Operating Cost of Revenue
3,334 3,385 3,337 3,427 3,428 3,672 3,488 3,471 3,648 3,468 3,639
Total Operating Expenses
931 256 223 230 256 251 227 211 282 265 253
Selling, General & Admin Expense
239 233 226 231 247 279 230 217 286 266 223
Other Operating Expenses / (Income)
- - -7.00 -8.00 - - -7.00 -8.00 -8.00 -9.00 -5.00
Restructuring Charge
5.00 10 4.00 7.00 3.00 2.00 4.00 2.00 4.00 8.00 35
Total Other Income / (Expense), net
-44 -29 -47 -49 -36 -56 -52 -53 -51 -44 -79
Interest & Investment Income
-45 - -49 -51 -36 - -49 -55 -51 -48 -55
Other Income / (Expense), net
1.00 -2.00 2.00 2.00 0.00 1.00 -3.00 2.00 0.00 4.00 -24
Income Tax Expense
8.00 80 85 102 108 93 113 125 115 94 94
Net Income / (Loss) Attributable to Noncontrolling Interest
3.00 1.00 -1.00 2.00 -2.00 -2.00 2.00 2.00 2.00 8.00 7.00
Basic Earnings per Share
($2.91) $1.67 $2.09 $2.39 $2.72 $2.16 $2.79 $3.03 $2.87 $2.62 $2.60
Weighted Average Basic Shares Outstanding
137.51M 135.78M 135.21M 134.71M 133.43M 131.17M 128.72M 128.30M 127.86M 126.39M 125.79M
Diluted Earnings per Share
($2.91) $1.68 $2.07 $2.37 $2.68 $2.10 $2.77 $3.01 $2.82 $2.54 $2.56
Weighted Average Diluted Shares Outstanding
137.51M 135.78M 135.21M 134.71M 133.43M 131.17M 128.72M 128.30M 127.86M 126.39M 125.79M
Weighted Average Basic & Diluted Shares Outstanding
137.51M 135.78M 135.21M 134.71M 133.43M 131.17M 128.72M 128.30M 127.86M 126.39M 125.79M
Cash Dividends to Common per Share
$0.36 - $0.38 $0.38 - - $0.40 $0.40 - - $0.43

Annual Cash Flow Statements for Leidos

This table details how cash moves in and out of Leidos' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/30/2015 12/30/2016 12/29/2017 12/28/2018 1/3/2020 1/1/2021 12/31/2021 12/30/2022 12/29/2023 1/3/2025 1/2/2026
Net Change in Cash & Equivalents
13 -277 26 -53 348 -30 188 -192 267 199 213
Net Cash From Operating Activities
396 449 526 768 992 1,334 1,033 992 1,187 1,435 1,750
Net Cash From Continuing Operating Activities
396 449 526 768 992 1,334 1,033 992 1,187 1,435 1,750
Net Income / (Loss) Continuing Operations
-330 246 364 582 670 629 759 693 208 1,251 1,462
Consolidated Net Income / (Loss)
-323 246 364 582 670 629 759 693 208 1,251 1,462
Depreciation Expense
62 122 336 257 234 282 325 333 331 290 290
Non-Cash Adjustments To Reconcile Net Income
617 39 107 69 -21 124 64 139 792 140 109
Changes in Operating Assets and Liabilities, net
47 42 -295 -140 109 299 -115 -173 -144 -246 -111
Net Cash From Investing Activities
51 25 -71 -114 65 -2,815 -730 -313 -211 -142 -405
Net Cash From Continuing Investing Activities
51 26 -71 -114 65 -2,815 -730 -313 -211 -142 -405
Purchase of Property, Plant & Equipment
-29 -29 -81 -73 -121 -183 -104 -129 -207 -149 -125
Acquisitions
0.00 25 0.00 -81 -94 -2,655 -622 -192 -6.00 0.00 -293
Divestitures
0.00 23 0.00 0.00 178 0.00 0.00 15 2.00 0.00 9.00
Other Investing Activities, net
80 - 0.00 0.00 1.00 11 -4.00 -13 0.00 7.00 4.00
Net Cash From Financing Activities
-478 -751 -429 -707 -709 1,451 -113 -865 -715 -1,084 -1,145
Net Cash From Continuing Financing Activities
-478 -751 -429 -707 -709 1,451 -113 -865 -715 -1,084 -1,145
Repayment of Debt
-175 -307 -213 -76 -80 -5,512 -106 -545 -2,052 -19 -1,033
Repurchase of Common Equity
-215 -24 -31 -438 -458 -105 -270 -542 -246 -906 -944
Payment of Dividends
-95 -1,135 -198 -198 -198 -192 -161 -206 -210 -214 -227
Issuance of Debt
0.00 690 - 0.00 0.00 7,225 380 380 1,743 0.00 997
Issuance of Common Equity
7.00 25 13 14 27 35 44 48 50 55 62
Effect of Exchange Rate Changes
- - - - - - -2.00 -6.00 6.00 -10 13
Cash Interest Paid
- - - - 172 161 182 195 207 226 220
Cash Income Taxes Paid
- - - - 142 140 221 217 435 460 276

Quarterly Cash Flow Statements for Leidos

This table details how cash moves in and out of Leidos' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/29/2023 12/29/2023 3/29/2024 6/28/2024 9/27/2024 1/3/2025 4/4/2025 7/4/2025 10/3/2025 1/2/2026 4/3/2026
Net Change in Cash & Equivalents
491 -11 -131 194 385 -242 -67 96 77 107 -666
Net Cash From Operating Activities
795 304 113 374 656 299 58 486 711 495 301
Net Cash From Continuing Operating Activities
795 304 113 374 656 299 58 486 711 495 301
Net Income / (Loss) Continuing Operations
-396 230 283 324 362 282 365 393 369 335 335
Consolidated Net Income / (Loss)
-396 230 283 324 362 282 365 393 369 335 335
Depreciation Expense
82 83 69 71 71 79 69 72 74 75 72
Non-Cash Adjustments To Reconcile Net Income
726 23 14 28 28 70 20 26 33 30 58
Changes in Operating Assets and Liabilities, net
383 -32 -253 -49 195 -132 -396 -5.00 235 55 -164
Net Cash From Investing Activities
-52 -76 -12 -21 -23 -86 -22 -314 -36 -33 -2,359
Net Cash From Continuing Investing Activities
-52 -76 -12 -21 -23 -86 -22 -314 -36 -33 -2,359
Purchase of Property, Plant & Equipment
-50 -78 -17 -23 -23 -86 -22 -29 -31 -43 -31
Acquisitions
-2.00 - - - - - 0.00 - -7.00 -1.00 -2,338
Divestitures
- - - - - - 0.00 - - - 4.00
Other Investing Activities, net
- - 5.00 - - - 0.00 - 2.00 2.00 6.00
Net Cash From Financing Activities
-249 -245 -228 -159 -257 -440 -110 -83 -595 -357 1,393
Net Cash From Continuing Financing Activities
-249 -245 -228 -159 -257 -440 -110 -83 -595 -357 1,393
Repayment of Debt
-5.00 -4.00 -4.00 -5.00 -5.00 -5.00 -536 -36 -456 -5.00 -20
Repurchase of Common Equity
-1.00 -202 -183 -114 -203 -406 -528 -9.00 -102 -305 -243
Payment of Dividends
-55 -52 -54 -53 -51 -56 -58 -54 -53 -62 -57
Issuance of Debt
-200 - 0.00 - - - 997 - - - 1,697
Issuance of Common Equity
12 13 13 13 2.00 27 15 16 16 15 16
Effect of Exchange Rate Changes
-3.00 6.00 -4.00 - 9.00 -15 7.00 7.00 -3.00 2.00 -1.00
Cash Interest Paid
64 47 61 46 60 59 51 49 77 43 68
Cash Income Taxes Paid
46 110 2.00 161 113 184 -4.00 166 17 97 -5.00

Annual Balance Sheets for Leidos

This table presents Leidos' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/1/2016 12/30/2016 12/29/2017 12/28/2018 1/3/2020 1/1/2021 12/31/2021 12/30/2022 12/29/2023 1/3/2025 1/2/2026
Total Assets
3,370 9,132 8,990 8,770 9,367 12,511 13,261 13,071 12,695 13,010 13,493
Total Current Assets
1,793 2,381 2,674 2,839 2,812 3,339 3,619 3,643 4,005 4,334 4,814
Cash & Equivalents
656 376 390 327 668 524 727 516 777 849 1,108
Accounts Receivable
921 1,657 1,831 1,877 1,734 2,137 2,189 2,350 2,429 2,645 2,708
Inventories, net
- - - - 72 276 274 287 310 315 342
Other Current Assets
- - 453 543 338 402 429 490 489 525 656
Plant, Property, & Equipment, net
142 259 232 237 0.00 0.00 670 847 961 991 961
Total Noncurrent Assets
1,435 6,476 6,084 5,694 6,555 9,172 8,972 8,581 7,729 7,685 7,718
Goodwill
1,207 4,622 4,974 4,860 4,912 6,313 6,744 6,696 6,112 6,084 6,342
Intangible Assets
25 1,589 856 652 530 1,216 1,177 952 667 517 458
Noncurrent Deferred & Refundable Income Taxes
8.00 - - - - - - - - 203 48
Other Noncurrent Operating Assets
195 265 254 182 1,113 1,643 1,051 933 950 881 870
Total Liabilities & Shareholders' Equity
3,370 9,132 8,990 8,770 9,367 12,511 13,261 13,071 12,695 13,010 13,493
Total Liabilities
2,302 5,985 5,607 5,459 5,950 8,640 8,917 8,718 8,437 8,550 8,531
Total Current Liabilities
1,040 2,016 2,202 2,059 2,333 2,907 3,229 3,947 2,990 3,560 2,827
Short-Term Debt
2.00 62 55 72 61 100 483 992 18 618 20
Accounts Payable
761 1,427 1,639 1,491 1,837 2,175 2,141 2,254 2,277 2,131 1,988
Current Employee Benefit Liabilities
268 483 487 473 435 632 605 701 695 811 819
Total Noncurrent Liabilities
1,262 3,969 3,405 3,400 3,617 5,733 5,688 4,771 5,447 4,990 5,704
Long-Term Debt
1,079 3,225 3,056 3,052 2,925 4,644 4,593 3,928 4,664 4,052 4,628
Noncurrent Deferred & Payable Income Tax Liabilities
34 540 220 170 184 234 239 40 - 2.00 221
Other Noncurrent Operating Liabilities
149 204 129 178 508 855 856 803 783 936 855
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,068 3,147 3,383 3,311 3,417 3,871 4,344 4,353 4,258 4,460 4,962
Total Preferred & Common Equity
1,068 3,135 3,370 3,308 3,413 3,862 4,291 4,299 4,201 4,412 4,916
Total Common Equity
1,068 3,135 3,370 3,308 3,413 3,862 4,291 4,299 4,201 4,412 4,916
Common Stock
1,353 3,316 3,344 2,966 2,587 2,580 2,423 2,005 1,885 1,112 319
Retained Earnings
-277 -177 -7.00 372 896 1,328 1,880 2,367 2,364 3,410 4,647
Accumulated Other Comprehensive Income / (Loss)
-8.00 -4.00 33 -30 -70 -46 -12 -73 -48 -110 -50
Noncontrolling Interest
0.00 12 13 3.00 4.00 9.00 53 54 57 48 46

Quarterly Balance Sheets for Leidos

This table presents Leidos' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 6/30/2023 9/29/2023 12/29/2023 3/29/2024 6/28/2024 9/27/2024 1/3/2025 4/4/2025 7/4/2025 10/3/2025 4/3/2026
Total Assets
13,026 12,757 12,695 12,817 12,909 13,338 13,104 13,197 13,549 13,542 15,387
Total Current Assets
3,576 3,991 4,005 4,150 4,229 4,665 4,428 4,549 4,781 4,849 4,403
Cash & Equivalents
329 750 777 633 823 1,185 943 842 930 974 457
Accounts Receivable
2,478 2,452 2,429 2,713 2,615 2,706 2,645 2,906 2,915 2,970 3,028
Inventories, net
310 295 310 318 333 323 315 347 364 360 336
Other Current Assets
459 494 489 486 458 451 525 454 572 545 582
Plant, Property, & Equipment, net
928 935 961 972 984 992 991 977 973 963 966
Total Noncurrent Assets
8,522 7,831 7,729 7,695 7,696 7,681 7,685 7,671 7,795 7,730 10,018
Goodwill
6,701 6,079 6,112 6,099 6,102 6,123 6,084 6,098 6,359 6,342 8,094
Intangible Assets
851 713 667 629 592 558 517 489 515 496 993
Noncurrent Deferred & Refundable Income Taxes
- - - - - - - - - 32 35
Other Noncurrent Operating Assets
970 1,039 950 967 1,002 1,000 1,084 1,084 921 860 896
Total Liabilities & Shareholders' Equity
13,026 12,757 12,695 12,817 12,909 13,338 13,104 13,197 13,549 13,542 15,387
Total Liabilities
8,373 8,554 8,437 8,504 8,399 8,671 8,644 8,895 8,842 8,588 10,323
Total Current Liabilities
2,855 3,040 2,990 3,084 3,505 3,782 3,654 2,961 2,948 2,986 3,152
Short-Term Debt
219 18 18 43 567 592 618 119 119 19 320
Accounts Payable
1,970 2,221 2,277 2,301 2,235 2,287 2,225 2,178 2,003 2,158 2,145
Current Employee Benefit Liabilities
666 801 695 740 703 903 811 664 826 809 687
Total Noncurrent Liabilities
5,518 5,514 5,447 5,420 4,894 4,889 4,990 5,934 5,894 5,602 7,171
Long-Term Debt
4,670 4,667 4,664 4,636 4,109 4,081 4,052 5,014 4,985 4,632 6,014
Noncurrent Deferred & Payable Income Tax Liabilities
16 6.00 - - - - - - - 122 280
Other Noncurrent Operating Liabilities
832 841 783 784 785 808 938 920 909 848 877
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
4,653 4,203 4,258 4,313 4,510 4,667 4,460 4,302 4,707 4,954 5,064
Total Preferred & Common Equity
4,597 4,146 4,201 4,258 4,455 4,614 4,412 4,257 4,662 4,909 5,013
Total Common Equity
4,597 4,146 4,201 4,258 4,455 4,614 4,412 4,257 4,662 4,909 5,013
Common Stock
2,024 2,055 1,885 1,735 1,654 1,469 1,112 619 650 588 117
Retained Earnings
2,636 2,186 2,364 2,595 2,866 3,179 3,410 3,721 4,061 4,375 4,921
Accumulated Other Comprehensive Income / (Loss)
-63 -95 -48 -72 -65 -34 -110 -83 -49 -54 -25
Noncontrolling Interest
56 57 57 55 55 53 48 45 45 45 51

Annual Metrics And Ratios for Leidos

This table displays calculated financial ratios and metrics derived from Leidos' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/30/2015 12/30/2016 12/29/2017 12/28/2018 1/3/2020 1/1/2021 12/31/2021 12/30/2022 12/29/2023 1/3/2025 1/2/2026
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-12.02% 39.11% 44.40% 0.24% 8.83% 10.84% 23.42% 4.80% 7.24% 7.93% 3.07%
EBITDA Growth
-162.55% 451.02% 71.12% 11.78% 24.92% -0.41% 20.20% -7.36% -33.29% 124.31% 13.20%
EBIT Growth
-234.84% 288.52% 35.28% 36.96% 36.85% -5.31% 21.67% -5.73% -43.32% 197.89% 15.28%
NOPAT Growth
-196.28% 310.18% 64.44% 34.71% 1.17% 12.32% 28.19% -11.16% -62.34% 335.08% 15.82%
Net Income Growth
-296.95% 176.16% 47.97% 59.89% 15.12% -6.12% 20.67% -8.70% -69.99% 501.44% 16.87%
EPS Growth
-324.74% 153.90% 1.28% 59.66% 21.05% -5.22% 41.74% -11.76% -70.97% 540.28% 20.82%
Operating Cash Flow Growth
28.16% 13.38% 17.15% 46.01% 29.17% 34.48% -22.56% -7.94% 17.44% 19.49% 21.95%
Free Cash Flow Firm Growth
410.31% -628.99% 110.85% 68.80% 29.53% -254.87% 238.66% 331.83% 16.20% 49.86% 9.22%
Invested Capital Growth
-77.88% 305.41% 0.92% -1.34% -5.03% 41.08% 7.44% 1.47% -6.78% 0.29% 2.67%
Revenue Q/Q Growth
-8.31% 23.00% -0.58% 1.30% 0.00% 2.48% 3.54% 2.90% 1.87% 2.37% -0.91%
EBITDA Q/Q Growth
-120.14% 919.05% -3.29% 8.58% 0.00% 1.40% 0.07% 0.14% 10.64% 2.86% 2.17%
EBIT Q/Q Growth
-261.56% 373.61% -9.81% 15.14% 0.00% 0.96% -1.03% 1.69% 17.59% 3.56% 2.67%
NOPAT Q/Q Growth
-245.60% 410.20% 29.83% 2.50% 0.00% 2.01% -1.91% 2.65% 20.63% 3.60% 3.38%
Net Income Q/Q Growth
-292.95% 193.18% 17.04% 14.79% 0.00% 2.61% -5.38% 1.16% 31.65% 4.34% 3.76%
EPS Q/Q Growth
-290.36% 158.60% 23.96% 15.15% 0.00% 2.35% -2.41% 2.45% 35.85% 4.77% 4.11%
Operating Cash Flow Q/Q Growth
-52.05% 29.77% 8.90% -7.25% 0.00% -14.21% 68.66% -8.06% 18.15% -0.36% 16.20%
Free Cash Flow Firm Q/Q Growth
-53.49% 11.57% 7.94% -13.92% 249.34% -18.35% 1,172.35% -67.16% 98.07% 3.12% 28.33%
Invested Capital Q/Q Growth
4.23% -1.77% -0.39% 2.01% 1.85% 4.68% 0.16% 10.15% 0.31% 0.39% -1.49%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
26.31% 13.30% 14.08% 14.75% 13.95% 14.13% 29.32% 28.95% 14.54% 16.79% 18.04%
EBITDA Margin
-5.81% 7.33% 8.68% 9.68% 11.11% 9.99% 10.74% 19.70% 6.13% 12.74% 13.99%
Operating Margin
-4.23% 5.78% 5.50% 7.17% 8.22% 8.00% 16.77% 7.56% 4.02% 10.97% 12.28%
EBIT Margin
-8.26% 5.59% 5.24% 7.16% 9.00% 7.69% 16.76% 15.07% 3.98% 11.00% 12.30%
Profit (Net Income) Margin
-12.76% 3.49% 3.58% 5.71% 6.04% 5.12% 5.53% 4.81% 1.35% 7.51% 8.51%
Tax Burden Percent
114.13% 77.36% 92.62% 95.41% 77.37% 80.54% 78.49% 156.43% 51.61% 76.33% 76.58%
Interest Burden Percent
135.41% 80.71% 73.73% 83.56% 86.69% 82.56% 169.51% 164.23% 65.53% 89.47% 90.39%
Effective Tax Rate
0.00% 22.64% 7.38% 4.59% 22.63% 19.46% 43.02% 43.57% 48.39% 23.67% 23.42%
Return on Invested Capital (ROIC)
-15.19% 8.33% 8.50% 11.47% 11.99% 11.46% 21.55% 9.75% 3.79% 17.06% 19.25%
ROIC Less NNEP Spread (ROIC-NNEP)
-69.18% 4.21% 3.06% 7.25% 10.58% 6.46% 14.95% 6.14% 1.08% 13.30% 15.09%
Return on Net Nonoperating Assets (RNNOA)
-33.33% 3.34% 2.65% 5.92% 7.93% 5.80% 7.70% 12.47% 1.04% 11.64% 11.79%
Return on Equity (ROE)
-48.52% 11.67% 11.15% 17.39% 19.92% 17.26% 36.96% 31.87% 4.83% 28.70% 31.03%
Cash Return on Invested Capital (CROIC)
81.52% -112.53% 7.58% 12.82% 17.15% -22.62% 7.20% 18.04% 10.81% 16.76% 16.61%
Operating Return on Assets (OROA)
-5.55% 6.30% 5.88% 8.22% 11.02% 8.65% 17.86% 16.48% 4.77% 14.20% 15.94%
Return on Assets (ROA)
-17.15% 3.94% 4.02% 6.55% 7.39% 5.75% 11.78% 10.53% 1.61% 9.70% 11.03%
Return on Common Equity (ROCE)
-24.26% 11.64% 11.11% 17.35% 19.90% 17.23% 18.34% 31.48% 4.77% 28.35% 30.72%
Return on Equity Simple (ROE_SIMPLE)
-60.49% 7.85% 10.80% 17.59% 19.63% 16.29% 35.38% 32.24% 4.95% 28.35% 0.00%
Net Operating Profit after Tax (NOPAT)
-150 315 518 697 706 792 904 851 321 1,394 1,615
NOPAT Margin
-2.96% 4.47% 5.09% 6.84% 6.36% 6.44% 6.58% 11.82% 2.08% 8.37% 9.40%
Net Nonoperating Expense Percent (NNEP)
54.00% 4.12% 5.44% 4.22% 1.41% 5.00% 6.78% 7.22% 2.71% 3.76% 4.16%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 9.18% 3.59% 15.27% 16.81%
Cost of Revenue to Revenue
86.85% 86.70% 85.92% 85.25% 86.05% 85.87% 170.68% 171.05% 85.46% 83.21% 81.96%
SG&A Expenses to Revenue
12.25% 5.99% 7.25% 7.15% 6.21% 6.26% 12.46% 13.21% 6.10% 5.90% 5.82%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
34.76% 7.53% 8.58% 7.58% 5.73% 6.12% 12.67% 14.00% 10.71% 5.76% 5.74%
Earnings before Interest and Taxes (EBIT)
-209 394 533 730 999 946 1,151 1,085 615 1,832 2,112
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-147 516 883 987 1,233 1,228 1,476 1,418 946 2,122 2,402
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.56 2.16 2.61 2.18 3.86 3.68 2.80 6.60 3.51 4.45 4.77
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.37 0.96 0.87 0.71 1.19 1.15 0.87 1.97 0.95 1.18 1.37
Price to Earnings (P/E)
0.00 27.78 24.06 12.42 19.75 22.61 15.95 20.45 74.00 15.66 16.20
Dividend Yield
5.04% 33.10% 2.20% 2.66% 1.42% 1.36% 3.27% 2.81% 1.36% 1.05% 0.89%
Earnings Yield
0.00% 3.60% 4.16% 8.05% 5.06% 4.42% 6.27% 4.89% 1.35% 6.39% 6.17%
Enterprise Value to Invested Capital (EV/IC)
3.11 1.60 1.89 1.66 2.70 2.28 3.81 4.26 2.29 2.86 3.18
Enterprise Value to Revenue (EV/Rev)
0.92 1.38 1.13 0.98 1.40 1.50 2.41 2.59 1.21 1.41 1.57
Enterprise Value to EBITDA (EV/EBITDA)
0.00 18.80 13.07 10.15 12.56 15.00 22.57 26.40 19.75 11.03 11.26
Enterprise Value to EBIT (EV/EBIT)
0.00 24.62 21.65 13.72 15.51 19.48 14.26 17.02 30.39 12.78 12.80
Enterprise Value to NOPAT (EV/NOPAT)
0.00 30.81 22.29 14.36 21.96 23.25 18.15 44.04 58.30 16.79 16.74
Enterprise Value to Operating Cash Flow (EV/OCF)
5.83 21.61 21.94 13.04 15.62 13.81 15.89 18.61 16.04 16.82 15.45
Enterprise Value to Free Cash Flow (EV/FCFF)
5.79 0.00 24.99 12.85 15.35 0.00 112.48 23.46 20.43 17.08 19.40
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
2.02 1.04 0.92 0.94 0.87 1.23 2.34 2.26 1.10 1.05 0.94
Long-Term Debt to Equity
1.01 1.02 0.90 0.92 0.86 1.20 2.11 1.80 1.10 0.91 0.93
Financial Leverage
0.96 0.79 0.87 0.82 0.75 0.90 2.09 2.01 0.96 0.88 0.78
Leverage Ratio
5.66 2.97 2.78 2.65 2.70 3.00 6.27 6.06 2.99 2.96 2.81
Compound Leverage Factor
7.66 2.39 2.05 2.22 2.34 2.48 5.32 4.97 1.96 2.65 2.54
Debt to Total Capital
100.61% 51.09% 47.91% 48.55% 46.63% 55.07% 53.89% 53.06% 52.37% 51.15% 48.37%
Short-Term Debt to Total Capital
0.09% 0.96% 0.85% 1.12% 0.95% 1.16% 10.25% 10.70% 0.20% 6.77% 0.21%
Long-Term Debt to Total Capital
50.21% 50.12% 47.06% 47.43% 45.68% 53.91% 97.52% 84.72% 52.17% 44.38% 48.16%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.19% 0.20% 0.05% 0.06% 0.10% 0.56% 1.16% 0.64% 0.53% 0.48%
Common Equity to Total Capital
49.70% 48.73% 51.89% 51.41% 53.30% 44.83% 45.55% 92.72% 46.99% 48.32% 51.16%
Debt to EBITDA
-14.71 6.37 3.52 3.17 2.42 3.86 6.93 3.47 4.95 2.20 1.94
Net Debt to EBITDA
-5.78 5.64 3.08 2.83 1.88 3.44 5.93 6.24 4.13 1.76 1.47
Long-Term Debt to EBITDA
-14.68 6.25 3.46 3.09 2.37 3.78 3.11 2.77 4.93 1.91 1.93
Debt to NOPAT
-14.43 10.44 6.01 4.48 4.23 5.99 11.33 11.63 14.61 3.35 2.88
Net Debt to NOPAT
-5.67 9.25 5.26 4.01 3.29 5.33 4.81 5.18 12.18 2.67 2.19
Long-Term Debt to NOPAT
-14.41 10.24 5.90 4.38 4.15 5.86 5.08 9.28 14.55 2.91 2.87
Altman Z-Score
3.89 1.61 2.33 2.40 3.06 2.41 4.74 5.15 2.78 3.53 4.10
Noncontrolling Interest Sharing Ratio
0.00% 0.28% 0.38% 0.24% 0.10% 0.18% 1.51% 2.46% 1.29% 1.20% 1.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.72 1.18 1.21 1.38 1.21 1.15 2.24 1.85 1.34 1.21 1.70
Quick Ratio
3.03 1.01 1.01 1.07 1.03 0.92 0.90 1.45 1.07 0.98 1.35
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
804 -4,254 462 779 1,010 -1,564 302 787 915 1,370 1,394
Operating Cash Flow to CapEx
1,365.52% 1,726.92% 720.55% 1,052.05% 3,968.00% 780.12% 1,986.54% 1,613.01% 562.80% 946.94% 1,400.00%
Free Cash Flow to Firm to Interest Expense
10.72 -49.47 3.30 5.65 7.59 -8.73 1.64 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
5.28 5.22 3.76 5.57 7.46 7.45 11.23 4.98 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
9.79 4.92 3.24 5.04 7.27 6.50 10.10 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
2.69 1.13 1.12 1.15 1.22 1.12 1.07 2.19 1.20 1.29 1.30
Accounts Receivable Turnover
10.11 5.46 5.83 5.50 6.14 6.35 12.70 12.69 6.46 6.57 6.42
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 60.69 42.63 43.89 44.20 44.36 42.85
Fixed Asset Turnover
32.46 35.13 41.43 43.47 0.00 0.00 0.00 37.96 17.08 17.07 17.60
Accounts Payable Turnover
5.95 5.58 5.70 5.55 5.74 5.26 5.43 5.60 5.82 6.16 6.83
Days Sales Outstanding (DSO)
72.20 66.80 62.59 66.38 59.40 57.45 114.94 115.08 56.49 55.58 56.88
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 6.01 17.12 16.63 8.26 8.23 8.52
Days Payable Outstanding (DPO)
122.61 65.40 64.04 65.73 63.62 69.34 134.38 65.15 62.67 59.26 53.41
Cash Conversion Cycle (CCC)
10.90 1.41 -1.44 0.65 -4.22 -5.87 -2.31 1.42 2.08 4.54 11.99
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,496 6,065 6,121 6,039 5,735 8,091 8,693 8,757 8,163 8,187 8,502
Invested Capital Turnover
5.13 1.86 1.67 1.68 1.88 1.78 3.27 3.30 1.82 2.04 2.05
Increase / (Decrease) in Invested Capital
-954 4,569 56 -82 -304 2,356 602 64 -594 24 221
Enterprise Value (EV)
2,307 9,701 11,541 10,017 15,493 18,425 16,413 18,465 18,687 23,410 27,044
Market Capitalization
1,882 6,778 8,807 7,217 13,171 14,196 12,011 14,007 14,725 19,635 23,458
Book Value per Share
$14.42 $20.85 $22.28 $22.09 $24.11 $27.14 $30.58 $31.45 $30.55 $33.07 $38.45
Tangible Book Value per Share
($2.21) ($20.46) ($16.26) ($14.72) ($14.33) ($25.77) ($25.87) ($24.50) ($18.75) ($16.41) ($14.74)
Total Capital
2,149 6,434 6,494 6,435 6,403 8,615 9,420 9,273 8,940 9,130 9,610
Total Debt
1,081 3,287 3,111 3,124 2,986 4,744 5,076 4,920 4,682 4,670 4,648
Total Long-Term Debt
1,079 3,225 3,056 3,052 2,925 4,644 4,593 3,928 4,664 4,052 4,628
Net Debt
425 2,911 2,721 2,797 2,318 4,220 4,349 4,404 3,905 3,727 3,540
Capital Expenditures (CapEx)
29 26 73 73 25 171 104 123 207 147 125
Debt-free, Cash-free Net Working Capital (DFCFNWC)
99 51 137 525 -128 8.00 146 172 256 449 899
Debt-free Net Working Capital (DFNWC)
755 427 527 852 540 532 873 688 1,033 1,392 2,007
Net Working Capital (NWC)
753 365 472 780 479 432 390 -304 1,015 774 1,987
Net Nonoperating Expense (NNE)
173 69 154 115 36 163 145 158 113 143 153
Net Nonoperating Obligations (NNO)
428 2,918 2,738 2,728 2,318 4,220 4,349 4,404 3,905 3,727 3,540
Total Depreciation and Amortization (D&A)
62 122 350 257 234 282 325 333 331 290 290
Debt-free, Cash-free Net Working Capital to Revenue
1.96% 0.72% 1.35% 5.15% -1.15% 0.07% 2.13% 2.39% 1.66% 2.69% 5.23%
Debt-free Net Working Capital to Revenue
14.91% 6.06% 5.18% 8.36% 4.87% 4.33% 12.71% 9.56% 6.69% 8.35% 11.69%
Net Working Capital to Revenue
14.87% 5.18% 4.64% 7.65% 4.32% 3.51% 2.84% -4.22% 6.57% 4.65% 11.57%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $2.39 $2.41 $3.85 $4.66 $4.42 $5.34 $5.00 $1.45 $9.36 $11.31
Adjusted Weighted Average Basic Shares Outstanding
0.00 150.35M 151.46M 146.16M 141.40M 141.89M 140.51M 136.94M 135.78M 131.17M 126.39M
Adjusted Diluted Earnings per Share
$0.00 $2.35 $2.38 $3.80 $4.60 $4.36 $5.27 $4.96 $1.44 $9.22 $11.14
Adjusted Weighted Average Diluted Shares Outstanding
0.00 150.35M 151.46M 146.16M 141.40M 141.89M 140.51M 136.94M 135.78M 131.17M 126.39M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 150.35M 151.46M 146.16M 141.40M 141.89M 140.51M 136.94M 135.78M 131.17M 126.39M
Normalized Net Operating Profit after Tax (NOPAT)
249 398 646 739 709 834 925 896 687 1,407 1,629
Normalized NOPAT Margin
9.84% 5.66% 6.36% 7.25% 6.40% 6.78% 6.74% 12.44% 4.45% 8.44% 9.49%
Pre Tax Income Margin
-5.59% 4.52% 3.86% 5.98% 7.81% 6.35% 14.08% 12.31% 2.61% 9.84% 11.12%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-5.57 4.58 3.81 5.29 7.51 5.28 12.51 5.45 0.00 0.00 0.00
NOPAT to Interest Expense
-2.00 3.66 3.70 5.05 5.31 4.43 4.91 4.28 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
-3.17 4.28 3.29 4.76 7.32 4.33 11.38 4.83 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
-4.77 3.36 3.18 4.53 5.12 3.47 8.70 3.66 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-58.82% 461.38% 54.40% 34.02% 29.55% 30.52% 21.21% 59.45% 100.96% 17.11% 15.53%
Augmented Payout Ratio
-191.95% 471.14% 62.91% 109.28% 97.91% 47.22% 113.57% 215.87% 219.23% 89.53% 80.10%

Quarterly Metrics And Ratios for Leidos

This table displays calculated financial ratios and metrics derived from Leidos' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/29/2023 12/29/2023 3/29/2024 6/28/2024 9/27/2024 1/3/2025 4/4/2025 7/4/2025 10/3/2025 1/2/2026 4/3/2026
DEI Shares Outstanding
- - - - - - - - - - 126,392,684.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 126,392,684.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 2.60
Growth Metrics
- - - - - - - - - - -
Revenue Growth
8.68% 7.65% 7.46% 7.66% 6.86% 9.67% 6.79% 2.93% 6.66% -3.62% 3.65%
EBITDA Growth
-171.88% 25.93% 41.69% 32.37% 332.02% 13.35% 22.63% 17.70% 3.75% 10.18% -6.71%
EBIT Growth
-223.62% 34.46% 59.77% 44.55% 254.03% 17.55% 26.38% 20.13% 3.68% 13.03% -8.16%
NOPAT Growth
-212.79% 23.34% 52.01% 42.41% 268.98% 18.20% 26.81% 19.91% 2.63% 16.67% -1.98%
Net Income Growth
-341.46% 27.78% 72.56% 54.29% 191.41% 22.61% 28.98% 21.30% 1.93% 18.79% -8.22%
EPS Growth
-348.72% 29.23% 76.92% 58.00% 192.10% 25.00% 33.82% 27.00% 5.22% 20.95% -7.58%
Operating Cash Flow Growth
9.05% 143.20% 164.29% 128.05% -17.48% -1.64% -48.67% 27.56% 9.89% 68.37% 418.97%
Free Cash Flow Firm Growth
-107.08% 462.72% 2,096.57% 1,954.53% 1,070.48% -66.05% -83.88% -107.00% -117.91% -25.29% -1,243.07%
Invested Capital Growth
-2.35% -6.78% -8.13% -9.23% 0.21% 0.29% 2.80% 6.19% 5.84% 2.67% 27.32%
Revenue Q/Q Growth
2.16% 1.50% -0.13% 3.95% 1.40% 4.18% -2.75% 0.19% 5.08% -5.86% 4.59%
EBITDA Q/Q Growth
-161.11% 274.70% 9.95% 12.76% 7.12% -14.65% 18.96% 8.22% -5.58% -9.36% 0.72%
EBIT Q/Q Growth
-201.52% 207.16% 16.16% 14.39% 8.18% -18.22% 24.88% 8.73% -6.63% -10.84% 1.47%
NOPAT Q/Q Growth
-192.71% 213.88% 19.16% 13.20% 10.01% -20.34% 27.83% 7.04% -5.85% -9.44% 7.40%
Net Income Q/Q Growth
-288.57% 158.08% 23.04% 14.49% 11.73% -22.10% 29.43% 7.67% -6.11% -9.21% 0.00%
EPS Q/Q Growth
-294.00% 157.73% 23.21% 14.49% 13.08% -21.64% 31.90% 8.66% -6.31% -9.93% 0.79%
Operating Cash Flow Q/Q Growth
384.76% -61.76% -79.28% 493.65% 75.40% -54.42% -80.60% 737.93% 46.30% -30.38% -39.19%
Free Cash Flow Firm Q/Q Growth
39.98% 2,298.57% 22.89% 14.36% -68.59% -23.09% -41.66% -149.67% 19.66% 317.80% -1,415.26%
Invested Capital Q/Q Growth
-11.67% 0.31% 2.40% 0.05% -2.49% 0.39% 4.96% 3.35% -2.82% -1.49% 28.69%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
14.97% 14.95% 16.05% 17.06% 18.19% 15.88% 17.83% 18.39% 18.37% 17.57% 17.30%
EBITDA Margin
-6.45% 11.11% 12.23% 13.26% 14.01% 11.48% 14.04% 15.17% 13.63% 13.12% 12.64%
Operating Margin
-8.57% 9.07% 10.44% 11.50% 12.32% 9.64% 12.49% 13.43% 11.97% 11.24% 11.55%
EBIT Margin
-8.54% 9.02% 10.49% 11.54% 12.32% 9.67% 12.41% 13.47% 11.97% 11.34% 11.00%
Profit (Net Income) Margin
-10.10% 5.78% 7.12% 7.84% 8.64% 6.46% 8.60% 9.24% 8.26% 7.96% 7.61%
Tax Burden Percent
102.06% 74.19% 76.90% 76.06% 77.02% 75.20% 76.36% 75.87% 76.24% 78.09% 78.09%
Interest Burden Percent
115.82% 86.35% 88.25% 89.31% 91.09% 88.86% 90.70% 90.40% 90.47% 89.94% 88.64%
Effective Tax Rate
0.00% 25.81% 23.10% 23.94% 22.98% 24.80% 23.64% 24.13% 23.76% 21.91% 21.91%
Return on Invested Capital (ROIC)
-11.04% 12.28% 14.45% 15.93% 18.95% 14.78% 19.05% 20.15% 18.85% 17.97% 16.00%
ROIC Less NNEP Spread (ROIC-NNEP)
-14.99% 11.37% 13.62% 15.04% 18.00% 13.88% 18.09% 19.14% 17.76% 17.03% 14.78%
Return on Net Nonoperating Assets (RNNOA)
-14.61% 10.97% 13.47% 13.81% 15.06% 12.15% 17.51% 16.67% 13.23% 13.31% 16.05%
Return on Equity (ROE)
-25.65% 23.25% 27.93% 29.74% 34.01% 26.93% 36.55% 36.82% 32.08% 31.28% 32.04%
Cash Return on Invested Capital (CROIC)
5.61% 10.81% 13.60% 16.09% 16.31% 16.76% 14.70% 11.99% 12.94% 16.61% -7.59%
Operating Return on Assets (OROA)
-10.02% 10.81% 12.71% 14.25% 15.36% 12.49% 16.16% 17.37% 15.44% 14.69% 13.34%
Return on Assets (ROA)
-11.84% 6.93% 8.62% 9.68% 10.78% 8.34% 11.19% 11.91% 10.65% 10.32% 9.23%
Return on Common Equity (ROCE)
-25.31% 22.95% 27.58% 29.38% 33.59% 26.61% 36.13% 36.42% 31.75% 30.96% 31.72%
Return on Equity Simple (ROE_SIMPLE)
3.81% 0.00% 7.68% 9.90% 25.99% 0.00% 31.31% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-235 268 319 361 397 317 405 433 408 369 397
NOPAT Margin
-6.00% 6.73% 8.03% 8.74% 9.49% 7.25% 9.53% 10.19% 9.13% 8.78% 9.02%
Net Nonoperating Expense Percent (NNEP)
3.96% 0.91% 0.83% 0.89% 0.95% 0.91% 0.95% 1.00% 1.09% 0.93% 1.21%
Return On Investment Capital (ROIC_SIMPLE)
- 3.00% - - - 3.47% 4.29% 4.42% 4.25% 3.84% 3.48%
Cost of Revenue to Revenue
85.03% 85.05% 83.95% 82.94% 81.81% 84.12% 82.17% 81.61% 81.63% 82.43% 82.70%
SG&A Expenses to Revenue
6.10% 5.85% 5.69% 5.59% 5.90% 6.39% 5.42% 5.10% 6.40% 6.32% 5.07%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
23.74% 6.43% 5.61% 5.57% 6.11% 5.75% 5.35% 4.96% 6.31% 6.30% 5.75%
Earnings before Interest and Taxes (EBIT)
-335 359 417 477 516 422 527 573 535 477 484
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-253 442 486 548 587 501 596 645 609 552 556
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.02 3.51 4.21 4.42 4.66 4.45 4.10 4.54 5.11 4.77 4.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.83 0.95 1.14 1.23 1.32 1.18 1.03 1.24 1.45 1.37 1.16
Price to Earnings (P/E)
85.12 74.00 55.87 45.13 17.95 15.66 13.10 15.11 17.86 16.20 14.21
Dividend Yield
1.58% 1.36% 1.13% 1.03% 0.95% 1.05% 1.17% 0.96% 0.82% 0.89% 1.05%
Earnings Yield
1.17% 1.35% 1.79% 2.22% 5.57% 6.39% 7.63% 6.62% 5.60% 6.17% 7.04%
Enterprise Value to Invested Capital (EV/IC)
2.03 2.29 2.64 2.82 3.07 2.86 2.54 2.86 3.34 3.18 2.38
Enterprise Value to Revenue (EV/Rev)
1.09 1.21 1.40 1.47 1.54 1.41 1.29 1.49 1.66 1.57 1.50
Enterprise Value to EBITDA (EV/EBITDA)
19.30 19.75 20.23 19.28 12.15 11.03 9.77 10.91 12.26 11.26 11.01
Enterprise Value to EBIT (EV/EBIT)
31.56 30.39 28.58 25.69 14.16 12.78 11.23 12.46 14.01 12.80 12.57
Enterprise Value to NOPAT (EV/NOPAT)
62.12 58.30 49.29 41.85 18.62 16.79 14.73 16.37 18.44 16.74 16.18
Enterprise Value to Operating Cash Flow (EV/OCF)
16.74 16.04 16.62 15.35 17.94 16.82 16.30 17.62 19.13 15.45 13.05
Enterprise Value to Free Cash Flow (EV/FCFF)
35.75 20.43 18.56 16.68 18.85 17.08 17.49 24.57 26.52 19.40 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.11 1.10 1.08 1.04 1.00 1.05 1.19 1.08 0.94 0.94 1.25
Long-Term Debt to Equity
1.11 1.10 1.07 0.91 0.87 0.91 1.17 1.06 0.94 0.93 1.19
Financial Leverage
0.97 0.96 0.99 0.92 0.84 0.88 0.97 0.87 0.74 0.78 1.09
Leverage Ratio
3.10 2.99 2.96 2.83 2.94 2.96 3.02 2.87 2.79 2.81 3.05
Compound Leverage Factor
3.59 2.58 2.61 2.53 2.68 2.63 2.74 2.60 2.53 2.53 2.71
Debt to Total Capital
52.71% 52.37% 52.04% 50.90% 50.03% 51.15% 54.40% 52.02% 48.42% 48.37% 55.57%
Short-Term Debt to Total Capital
0.20% 0.20% 0.48% 6.17% 6.34% 6.77% 1.26% 1.21% 0.20% 0.21% 2.81%
Long-Term Debt to Total Capital
52.51% 52.17% 51.56% 44.73% 43.69% 44.38% 53.14% 50.81% 48.22% 48.16% 52.76%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.64% 0.64% 0.61% 0.60% 0.57% 0.53% 0.48% 0.46% 0.47% 0.48% 0.45%
Common Equity to Total Capital
46.65% 46.99% 47.35% 48.50% 49.40% 48.32% 45.12% 47.52% 51.11% 51.16% 43.98%
Debt to EBITDA
5.48 4.95 4.30 3.82 2.27 2.20 2.30 2.19 1.98 1.94 2.68
Net Debt to EBITDA
4.60 4.13 3.72 3.15 1.69 1.76 1.92 1.79 1.56 1.47 2.49
Long-Term Debt to EBITDA
5.46 4.93 4.26 3.36 1.98 1.91 2.25 2.14 1.97 1.93 2.55
Debt to NOPAT
17.63 14.61 10.47 8.30 3.47 3.35 3.47 3.29 2.98 2.88 3.94
Net Debt to NOPAT
14.81 12.18 9.05 6.84 2.59 2.67 2.90 2.69 2.35 2.19 3.66
Long-Term Debt to NOPAT
17.56 14.55 10.37 7.29 3.03 2.91 3.39 3.21 2.96 2.87 3.74
Altman Z-Score
2.31 2.71 2.98 3.15 3.25 3.18 3.13 3.42 3.78 3.70 2.94
Noncontrolling Interest Sharing Ratio
1.32% 1.29% 1.25% 1.21% 1.24% 1.20% 1.16% 1.09% 1.02% 1.00% 1.03%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.31 1.34 1.35 1.21 1.23 1.21 1.54 1.62 1.62 1.70 1.40
Quick Ratio
1.05 1.07 1.09 0.98 1.03 0.98 1.27 1.30 1.32 1.35 1.11
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-39 862 1,059 1,211 380 293 171 -85 -68 148 -1,951
Operating Cash Flow to CapEx
1,590.00% 389.74% 370.59% 1,626.09% 2,852.17% 347.67% 263.64% 1,675.86% 2,293.55% 1,151.16% 970.97%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 21.62 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 1.29 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.94 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.17 1.20 1.21 1.23 1.25 1.29 1.30 1.29 1.29 1.30 1.21
Accounts Receivable Turnover
6.40 6.46 6.01 6.29 6.31 6.57 6.03 6.17 6.11 6.42 5.84
Inventory Turnover
44.70 44.20 43.13 41.94 43.94 44.36 42.15 40.34 41.81 42.85 41.66
Fixed Asset Turnover
18.87 17.08 16.59 16.74 16.89 17.07 17.38 17.43 17.73 17.60 17.84
Accounts Payable Turnover
5.74 5.82 6.04 6.41 6.02 6.16 6.26 6.63 6.42 6.83 6.58
Days Sales Outstanding (DSO)
57.03 56.49 60.75 58.06 57.83 55.58 60.56 59.18 59.77 56.88 62.49
Days Inventory Outstanding (DIO)
8.17 8.26 8.46 8.70 8.31 8.23 8.66 9.05 8.73 8.52 8.76
Days Payable Outstanding (DPO)
63.56 62.67 60.40 56.92 60.60 59.26 58.32 55.01 56.81 53.41 55.46
Cash Conversion Cycle (CCC)
1.64 2.08 8.81 9.85 5.54 4.54 10.90 13.22 11.68 11.99 15.80
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
8,138 8,163 8,359 8,363 8,155 8,187 8,593 8,881 8,631 8,502 10,941
Invested Capital Turnover
1.84 1.82 1.80 1.82 2.00 2.04 2.00 1.98 2.07 2.05 1.77
Increase / (Decrease) in Invested Capital
-196 -594 -740 -850 17 24 234 518 476 221 2,348
Enterprise Value (EV)
16,505 18,687 22,035 23,584 25,057 23,410 21,800 25,401 28,814 27,044 26,002
Market Capitalization
12,513 14,725 17,934 19,676 21,516 19,635 17,464 21,182 25,092 23,458 20,074
Book Value per Share
$30.19 $30.55 $31.49 $32.95 $34.25 $33.07 $32.45 $36.22 $38.26 $38.45 $39.66
Tangible Book Value per Share
($19.26) ($18.75) ($18.27) ($16.56) ($15.34) ($16.41) ($17.76) ($17.18) ($15.04) ($14.74) ($32.23)
Total Capital
8,888 8,940 8,992 9,186 9,340 9,130 9,435 9,811 9,605 9,610 11,398
Total Debt
4,685 4,682 4,679 4,676 4,673 4,670 5,133 5,104 4,651 4,648 6,334
Total Long-Term Debt
4,667 4,664 4,636 4,109 4,081 4,052 5,014 4,985 4,632 4,628 6,014
Net Debt
3,935 3,905 4,046 3,853 3,488 3,727 4,291 4,174 3,677 3,540 5,877
Capital Expenditures (CapEx)
50 78 17 23 23 86 22 29 31 43 31
Debt-free, Cash-free Net Working Capital (DFCFNWC)
219 256 476 468 290 449 865 1,022 908 899 1,114
Debt-free Net Working Capital (DFNWC)
969 1,033 1,109 1,291 1,475 1,392 1,707 1,952 1,882 2,007 1,571
Net Working Capital (NWC)
951 1,015 1,066 724 883 774 1,588 1,833 1,863 1,987 1,251
Net Nonoperating Expense (NNE)
161 38 36 37 35 35 40 40 39 34 62
Net Nonoperating Obligations (NNO)
3,935 3,905 4,046 3,853 3,488 3,727 4,291 4,174 3,677 3,540 5,877
Total Depreciation and Amortization (D&A)
82 83 69 71 71 79 69 72 74 75 72
Debt-free, Cash-free Net Working Capital to Revenue
1.45% 1.66% 3.03% 2.92% 1.78% 2.69% 5.11% 5.99% 5.24% 5.23% 6.43%
Debt-free Net Working Capital to Revenue
6.39% 6.69% 7.06% 8.06% 9.06% 8.35% 10.08% 11.45% 10.86% 11.69% 9.07%
Net Working Capital to Revenue
6.28% 6.57% 6.78% 4.52% 5.42% 4.65% 9.38% 10.75% 10.75% 11.57% 7.22%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($2.91) $1.67 $2.09 $2.39 $2.72 $2.16 $2.79 $3.03 $2.87 $2.62 $2.60
Adjusted Weighted Average Basic Shares Outstanding
137.51M 135.78M 135.21M 134.71M 133.43M 131.17M 128.72M 128.30M 127.86M 126.39M 125.79M
Adjusted Diluted Earnings per Share
($2.91) $1.68 $2.07 $2.37 $2.68 $2.10 $2.77 $3.01 $2.82 $2.54 $2.56
Adjusted Weighted Average Diluted Shares Outstanding
137.51M 135.78M 135.21M 134.71M 133.43M 131.17M 128.72M 128.30M 127.86M 126.39M 125.79M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
137.51M 135.78M 135.21M 134.71M 133.43M 131.17M 128.72M 128.30M 127.86M 126.39M 125.79M
Normalized Net Operating Profit after Tax (NOPAT)
249 275 322 367 404 318 408 435 411 376 424
Normalized NOPAT Margin
6.36% 6.92% 8.11% 8.87% 9.65% 7.29% 9.61% 10.22% 9.20% 8.93% 9.64%
Pre Tax Income Margin
-9.90% 7.79% 9.26% 10.31% 11.22% 8.59% 11.26% 12.18% 10.83% 10.20% 9.75%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 8.51 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 6.51 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 8.16 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 6.17 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
132.91% 100.96% 65.14% 48.53% 17.51% 17.11% 16.35% 15.62% 15.68% 15.53% 15.78%
Augmented Payout Ratio
167.09% 219.23% 183.18% 161.90% 76.06% 89.53% 110.20% 97.36% 89.85% 80.10% 61.80%

Financials Breakdown Chart

Key Financial Trends

Leidos (NYSE: LDOS) shows a business that is still generating solid profits and cash flow, but the latest quarter also highlights rising leverage and a cash balance that has been pressured by acquisitions and shareholder returns.

In Q1 2026, revenue rose to $4.4 billion, up modestly from $4.21 billion in Q4 2025 and $4.25 billion in Q1 2025. Gross profit improved to $761 million, and operating income came in at $508 million, suggesting the company remains profitable at the operating level even with restructuring charges in the mix. Net income attributable to common shareholders was $328 million, or $2.56 per diluted share.

Cash generation remains a strength, but it was much weaker in the latest quarter than in prior periods. Operating cash flow in Q1 2026 was $301 million, down from $495 million in Q4 2025 and $486 million in Q2 2025. A large $2.34 billion acquisition drove investing cash outflow and helped push cash and equivalents down to $457 million from $974 million at the end of Q3 2025.

The balance sheet also shows a meaningful change in capital structure. Long-term debt increased to $6.01 billion in Q1 2026 from $4.63 billion in Q3 2025, while total liabilities rose to $10.32 billion. Equity remains positive at $5.01 billion, but the jump in debt suggests management is leaning more heavily on leverage to fund growth and deal activity.

Over the last several years, Leidos has generally delivered consistent quarterly revenue in the $3.6 billion to $4.5 billion range, with recurring profitability and regular dividend payments. However, there are signs of pressure in margins and financing, especially when acquisition spending spikes or when working capital swings negatively.

  • Consistent profitability: Leidos has stayed solidly profitable across the last several years, with quarterly net income generally ranging from the mid-$100 millions to the $300+ million area.
  • Revenue growth remains stable: Q1 2026 revenue of $4.4 billion was above the prior year quarter’s $4.245 billion.
  • Operating margins are still healthy: Q1 2026 operating income of $508 million shows the core business continues to convert revenue into operating profit.
  • Strong recurring cash generation: Even after a weaker quarter, Q1 2026 operating cash flow was $301 million, which is still meaningful for a defense services company.
  • Shareholder returns continue: The company paid a $0.43 quarterly dividend in Q1 2026 and has also been repurchasing shares over time.
  • Recent quarter was affected by restructuring: Q1 2026 included a $35 million restructuring charge, which lowers near-term earnings quality but may support future efficiency.
  • Goodwill is large: Goodwill stood at $8.09 billion in Q1 2026, reflecting a heavy acquisition-driven asset base that investors should monitor for impairment risk.
  • Working capital can be volatile: Operating cash flow has swung significantly quarter to quarter because of changes in receivables, payables, and other operating assets/liabilities.
  • Acquisition strategy remains active: The latest quarter’s $2.34 billion acquisition outflow suggests continued M&A may be an important part of the company’s strategy.
  • Debt load increased sharply: Long-term debt rose to $6.01 billion in Q1 2026 from $4.63 billion in Q3 2025.
  • Cash declined materially: Cash and equivalents fell to $457 million from $974 million in Q3 2025.
  • Financing needs are growing: The company issued $1.697 billion of debt in Q1 2026, indicating more reliance on external funding.
  • Cash flow was pressured by acquisitions and buybacks: Combined acquisition spending and share repurchases consumed a large amount of capital in the latest quarter.

Bottom line: Leidos still looks like a profitable, cash-generating business, but the latest numbers show a more leveraged balance sheet and less cash flexibility after a major acquisition. For retail investors, the key question is whether the deal activity helps expand earnings enough to justify the extra debt and reduced cash cushion.

06/04/26 05:24 PM ETAI Generated. May Contain Errors.

Leidos Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Leidos' financial year ends in January. Their financial year 2026 ended on January 2, 2026.

Leidos' net income appears to be on an upward trend, with a most recent value of $1.46 billion in 2025, falling from -$323 million in 2015. The previous period was $1.25 billion in 2024. See Leidos' forecast for analyst expectations on what's next for the company.

Leidos' total operating income in 2025 was $2.11 billion, based on the following breakdown:
  • Total Gross Profit: $3.10 billion
  • Total Operating Expenses: $985 million

Over the last 10 years, Leidos' total revenue changed from $5.06 billion in 2015 to $17.17 billion in 2025, a change of 239.2%.

Leidos' total liabilities were at $8.53 billion at the end of 2025, a 0.2% decrease from 2024, and a 270.6% increase since 2015.

In the past 10 years, Leidos' cash and equivalents has ranged from $327 million in 2018 to $1.11 billion in 2025, and is currently $1.11 billion as of their latest financial filing in 2025.

Over the last 10 years, Leidos' book value per share changed from 14.42 in 2015 to 38.45 in 2025, a change of 166.7%.



Financial statements for NYSE:LDOS last updated on 5/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners